Table 4 Baseline features of responsive and unresponsive patients to neoadjuvant chemotherapy
From: Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Responsive | Unresponsive | P-value | |
|---|---|---|---|
Age, years | 62.2 (47.2–75.2) | 63.6 (42.9–75.4) | 0.726 |
Female sex, n | 2 | 2 | 0.201 |
ECOG-PS, median | 1 (0–2) | 1 (0–2) | 0.880 |
Smoking history, n | 9 | 13 | 0.150 |
Estimated GFR | 84 (48–113) | 85 (51–107) | 0.986 |
Hb, g/dl | 13.4 (11.5–16.4) | 12.4 (7.7–16.7) | 0.138 |
WBC, × 109/mm3 | 8.4 (3.7–13.9) | 7.2 (2.5–11.7) | 0.201 |
Neutrophil × 109/mm3 | 5.3 (2.5–11.6) | 4.7 (1.5–8.5) | 0.345 |
Platelet × 109/mm3 | 311 (189–641) | 248 (127–253) | 0.221 |
LDH, U/l | 192 (138–348) | 193 (127–253) | 0.646 |
CRP, mg/dl | 50 (2–198) | 25 (1.2–190) | 0.270 |
Albumin, g/dl | 44 (40–50) | 43 (3.2–50) | 0.271 |